Description and Brand Names
Drug information provided by: IBM Micromedex
US Brand Name
Midostaurin is used in combination with standard cytarabine and daunorubicin induction and cytarabine consolidation chemotherapy to treat newly diagnosed acute myeloid leukemia (AML) in patients who are FLT3 mutation-positive. Your doctor will perform a test to check for this mutation before you use this medicine.
This medicine is also used to treat aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN), or mast cell leukemia (MCL).
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms: